Freestone Capital Holdings »

Rhythm Pharmaceuticals shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $374k 3.7k 100.99
2025-06-30 $234k 3.7k 63.19
2024-12-31 $207k 3.7k 55.98

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Put Option (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)

View all positions for Freestone Capital Holdings

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
RA Capital Management
Baker Bros. Advisors
Vanguard Group
PRIMECAP Management Company
NEA Management Company
FMR
State Street Corporation
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Polar Capital Holdings
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals